Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72572-100

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 72572-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapto 01)

Chemical structure diagram of daptomycin, showing its molecular arrangement with connected atoms, bonds, and functional groups forming a cyclic lipopeptide structure.*

FDA Label Image

Principal Display Panel (350 mg Vial Carton)

Packaging label for DAPTOMycin for Injection 350 mg/vial, a lyophilized powder for intravenous injection by Civica, Inc. The label indicates the vial must be refrigerated, reconstituted with 0.9% sodium chloride injection to a final concentration of 50 mg/mL, and that it is for single-dose use with unused portions discarded. The product is distributed by Civica, Inc., manufactured by Xellia Pharmaceuticals USA, LLC, and made in Hyderabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.